Endocrinology
From the Journals
Does metformin reduce risk for death in COVID-19?
“It is still unclear whether metformin is truly a miracle drug or whether it is simply used more often among people who are healthier and who do...
News
Guidance covers glycemia in dexamethasone-treated COVID-19 patients
The latest document from the COVID-19 response group of the Association of British Clinical Diabetologists is a response to the recent RECOVERY...
From the Journals
Diabetic amputations soared amid Italian pandemic lockdown
Gangrene cases also skyrocketed, suggesting that patients failed to get proper care during national shutdown.
Feature
SGLT2 inhibitors have a breakout year
From the Journals
Unexpected rosuvastatin-canagliflozin adverse effect reported
From the Journals
COVID-19 taking financial toll on people in U.S. with diabetes
Unemployment and income loss caused by the pandemic are higher among those with diabetes than in the general U.S. population.
From the Journals
Low vitamin D linked to increased COVID-19 risk
A large study evaluates associations between low serum vitamin D levels and risks for acquiring COVID-19 and hospitalization.
Latest News
Delaying denosumab dose boosts risk for vertebral fractures
Physicians say patients may skip regular injections of the osteoporosis drug amid the pandemic.
From the Journals
Cleaner data confirm severe COVID-19 link to diabetes, hypertension
Initial reports that tied more severe COVID-19 disease to diabetes or hypertension used confounded data, but more refined data show similar links...
From the Journals
Even mild obesity raises severe COVID-19 risks
People with BMI of 30 kg/m2 or higher are at increased risk for severe illness, while BMI of 35 or greater dramatically increases the...
From the Journals
Guidance addresses elders with diabetes during COVID-19
Two geriatricians from the Joslin Diabetes Center offer advice for navigating the challenges associated with helping these vulnerable adults...